X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24717) 24717
Magazine Article (131) 131
Book Chapter (119) 119
Dissertation (112) 112
Conference Proceeding (86) 86
Newspaper Article (22) 22
Publication (16) 16
Book / eBook (15) 15
Government Document (12) 12
Newsletter (8) 8
Book Review (4) 4
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (12248) 12248
humans (9579) 9579
life sciences & biomedicine (9026) 9026
sulfones (8089) 8089
male (6560) 6560
animals (4924) 4924
sildenafil citrate (4341) 4341
sulfones - pharmacology (4200) 4200
physical sciences (3519) 3519
female (3366) 3366
sulfoxides, sulfones, sulfenes and derivatives (3118) 3118
sulfones - therapeutic use (2965) 2965
middle aged (2800) 2800
chemistry (2611) 2611
adult (2488) 2488
piperazines - therapeutic use (2460) 2460
purines (2366) 2366
sulfones - chemistry (2243) 2243
rats (1938) 1938
aged (1909) 1909
pharmacology & pharmacy (1888) 1888
sulfone (1785) 1785
erectile dysfunction - drug therapy (1672) 1672
sildenafil (1659) 1659
technology (1604) 1604
mice (1439) 1439
analysis (1406) 1406
piperazines - pharmacology (1384) 1384
sulfones - adverse effects (1325) 1325
treatment outcome (1261) 1261
sulfones - administration & dosage (1257) 1257
abridged index medicus (1223) 1223
polymers (1196) 1196
phosphodiesterase inhibitors - therapeutic use (1183) 1183
urology & nephrology (1118) 1118
polymer science (1113) 1113
dose-response relationship, drug (1066) 1066
piperazines - administration & dosage (994) 994
biochemistry & molecular biology (980) 980
engineering (957) 957
piperazines - adverse effects (952) 952
purines - therapeutic use (950) 950
membranes, artificial (933) 933
time factors (918) 918
research (889) 889
lactones - adverse effects (886) 886
vasodilator agents - therapeutic use (852) 852
double-blind method (808) 808
molecular structure (800) 800
general & internal medicine (787) 787
membranes (771) 771
organosulfur compounds (761) 761
sulfones - chemical synthesis (758) 758
catalysis (756) 756
cardiovascular system & cardiology (753) 753
poly (746) 746
old medline (718) 718
chemistry, multidisciplinary (700) 700
phosphodiesterase inhibitors - pharmacology (695) 695
lactones - therapeutic use (694) 694
rats, sprague-dawley (688) 688
medicine, general & internal (681) 681
erectile dysfunction (675) 675
chemical properties (669) 669
administration, oral (663) 663
purines - pharmacology (652) 652
vardenafil dihydrochloride (642) 642
materials science (639) 639
hypertension, pulmonary - drug therapy (636) 636
structure-activity relationship (629) 629
chemistry, physical (627) 627
cardiac & cardiovascular systems (624) 624
polymers - chemistry (604) 604
drug therapy (594) 594
impotence (585) 585
anti-inflammatory agents, non-steroidal - adverse effects (562) 562
cyclooxygenase inhibitors - adverse effects (559) 559
oncology (550) 550
risk factors (536) 536
cells, cultured (533) 533
celecoxib (526) 526
adolescent (521) 521
kinetics (521) 521
phosphodiesterase inhibitors - adverse effects (518) 518
disease models, animal (510) 510
cell line, tumor (505) 505
oxidation (502) 502
engineering, chemical (499) 499
rats, wistar (499) 499
cyclooxygenase inhibitors - therapeutic use (496) 496
synthesis (491) 491
sulfones - metabolism (483) 483
anti-inflammatory agents, non-steroidal - therapeutic use (481) 481
nitriles - pharmacology (476) 476
guanidines - pharmacology (475) 475
drug therapy, combination (472) 472
in vitro techniques (472) 472
purines - administration & dosage (468) 468
aged, 80 and over (467) 467
cell biology (463) 463
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Online Resources - Online (4) 4
UofT at Mississauga - Stacks (3) 3
Chemistry (A D Allen) - Stacks (2) 2
Chemistry (A D Allen) - In transit (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Robarts - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23779) 23779
German (426) 426
French (365) 365
Japanese (319) 319
Chinese (240) 240
Russian (167) 167
Spanish (132) 132
Portuguese (100) 100
Italian (89) 89
Polish (43) 43
Korean (39) 39
Dutch (24) 24
Norwegian (20) 20
Swedish (19) 19
Czech (11) 11
Hebrew (10) 10
Turkish (9) 9
Danish (8) 8
Finnish (8) 8
Hungarian (7) 7
Croatian (6) 6
Romanian (6) 6
Ukrainian (5) 5
Bulgarian (4) 4
Serbian (4) 4
Slovak (4) 4
Persian (3) 3
Arabic (1) 1
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1983, ISBN 9783718601899, Volume 3, no. 7., 259-287.
Book
Journal of the American Chemical Society, ISSN 0002-7863, 02/2017, Volume 139, Issue 6, pp. 2484 - 2503
This Article details the development of the iron-catalyzed conversion of olefins to radicals and their subsequent use in the construction of C–C bonds.... 
Alkenes - chemistry | Free Radicals - chemistry | Iron Compounds - chemistry | Sulfones - chemistry | Molecular Structure | Catalysis | Sulfones - chemical synthesis | Usage | Iron compounds | Olefins | Analysis | Chemical bonds | Chemical reactions | Chemical properties | Index Medicus
Journal Article
Angewandte Chemie (International ed.), ISSN 1433-7851, 11/2013, Volume 52, Issue 48, pp. 12679 - 12683
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2014, Volume 370, Issue 13, pp. 1189 - 1197
Ceritinib is 20 times as potent as crizotinib at inhibiting anaplastic lymphoma kinase (ALK) in vitro. In patients, ceritinib produced antitumor responses in... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Sulfones - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Young Adult | Recombination, Genetic | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Lung Neoplasms - genetics | Protein Kinase Inhibitors - pharmacokinetics | Carcinoma, Non-Small-Cell Lung - genetics | Pyrimidines - administration & dosage | Treatment Outcome | Sulfones - pharmacokinetics | Carcinoma, Non-Small-Cell Lung - mortality | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Maximum Tolerated Dose | Receptor Protein-Tyrosine Kinases - genetics | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Sulfones - administration & dosage | Antimitotic agents | Care and treatment | Dosage and administration | Research | Lung cancer, Non-small cell | Antineoplastic agents | Lung cancer | Diarrhea | Non-small cell lung carcinoma | Insulin-like growth factors | Dehydration | Kinases | Patients | Lymphoma | Gene amplification | Vomiting | Gene rearrangement | Hypophosphatemia | Antitumor activity | Mutation | Pharmaceutical industry | Protein-tyrosine kinase | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 12/2005, Volume 127, Issue 50, pp. 17622 - 17623
In situ generated azomethines from readily available precursors react with nitromethane in the presence of 120 mol % of CsOH·H2O and 12 mol % of quinine- and... 
Aldehydes | Sulfones | Chemical properties
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 01/2018, Volume 140, Issue 1, pp. 78 - 81
We describe the development of a nickel-catalyzed Suzuki–Miyaura cross-coupling of tertiary benzylic and allylic sulfones with arylboroxines. A variety of... 
Journal Article
Advanced synthesis & catalysis, ISSN 1615-4150, 03/2017, Volume 359, Issue 5, pp. 841 - 847
The atom‐economic and one‐pot regio‐ and stereoselective addition of sodium arenesulfinates to either alkynes or alkenes can be achieved with an iron(III)... 
β-chloroalkyl sulfones | β-haloalkenyl sulfones | alkenes | sodium arenesulfinates | alkynes | Olefins | Organosulfur compounds | Iron compounds | Iron | Catalysis | Alkenes | Sodium | Sulfones | Alkynes | Synthesis (chemistry) | Catalysts | Chlorides
Journal Article
Molecular cancer therapeutics, ISSN 1538-8514, 07/2007, Volume 6, Issue 7, pp. 2012 - 2021
With the development of targeted therapeutics, especially for small-molecule inhibitors, it is important to understand whether the observed in vivo efficacy... 
kinase inhibitor | Pharmacodynamics | pazopanib | angiogenesis | VEGF | Life Sciences & Biomedicine | Oncology | Science & Technology | Pyrimidines - blood | Humans | Fibroblast Growth Factor 2 - pharmacology | Antineoplastic Agents - administration & dosage | Indazoles - administration & dosage | Sulfones - pharmacology | Neovascularization, Pathologic - pathology | Phosphotyrosine - metabolism | Dose-Response Relationship, Drug | Sulfonamides - blood | Inhibitory Concentration 50 | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Cornea - pathology | Phosphorylation - drug effects | Sulfones - blood | Vascular Endothelial Growth Factor A - pharmacology | Protein Kinase Inhibitors - pharmacokinetics | Pyrimidines - administration & dosage | Pyrimidines - pharmacology | Sulfones - pharmacokinetics | Sulfonamides - pharmacology | Protein Kinase Inhibitors - blood | Sulfonamides - pharmacokinetics | Indazoles - pharmacology | Protein Kinase Inhibitors - administration & dosage | Indazoles - blood | Animals | Indazoles - pharmacokinetics | Cell-Free System | Mice, Nude | Antineoplastic Agents - blood | Cell Line, Tumor | Pyrimidines - pharmacokinetics | Mice | Protein Kinase Inhibitors - pharmacology | Sulfonamides - administration & dosage | Sulfones - administration & dosage | Index Medicus
Journal Article